What I wish I'd known before surgery: BRCA carriers' perspectives after bilateral salipingo-oophorectomy
- PMID: 20852945
- DOI: 10.1007/s10689-010-9384-z
What I wish I'd known before surgery: BRCA carriers' perspectives after bilateral salipingo-oophorectomy
Abstract
We retrospectively studied BRCA carriers with a history of prophylactic bilateral salingo-oophorectomy (PBSO) regarding: (1) their post-operative symptoms, (2) their recollection of pre-operative conversations with their health care providers regarding possible surgical side-effects and (3) what information they would have found helpful to have before surgery. Female BRCA carriers seen through the Yale Cancer Genetic Counseling Program who had PBSO were invited to participate in a questionnaire that assessed their recall of information they received pre-operatively compared with their post-operative knowledge and symptoms related to menopause, cognitive changes, loss of fertility, cancer risks, osteoporosis, heart disease, vasomotor symptoms, urogenital symptoms, sexuality and body image. The questionnaire also elicited written feedback from participants regarding their decision to have PBSO, what they wished they had known before surgery, advice for other BRCA carriers considering this surgery and advice for health care providers who counsel women about PBSO. Two hundred and ninety female BRCA carriers were invited to participate and 113 (39.0%) indicated they were interested. Of those, 99 (87.6%) returned their questionnaire and 98 (86.7%) responses were included in the analysis. The mean age at PBSO was 45.5 years (range: 32-63 years). The five most common "frequent" or "very frequent" post-surgical symptoms were: vaginal dryness (52.1%), changes in interest in sex (50.0%), sleep disturbances (46.7%), changes in sex life (43.9) and hot flashes (42.9%). The majority of women would have found it helpful to have more information regarding the impact of this surgery on their sex life (59.2%), the availability of sex counseling (57.1%) and the risk of coronary heart disease (57.1%). This study illustrates that while health care providers are discussing selected side effects of PBSO, women undergoing this surgery have other concerns that should be addressed. This information provides insights into the informational needs of BRCA carriers considering PBSO.
Similar articles
-
A pilot study of BRCA mutation carriers' knowledge about the clinical impact of prophylactic-oophorectomy and views on fertility consultation: a single-center pilot study.J Genet Couns. 2015 Feb;24(1):149-57. doi: 10.1007/s10897-014-9747-y. Epub 2014 Aug 15. J Genet Couns. 2015. PMID: 25120035
-
What made her give up her breasts: a qualitative study on decisional considerations for contralateral prophylactic mastectomy among breast cancer survivors undergoing BRCA1/2 genetic testing.Asian Pac J Cancer Prev. 2012;13(5):2241-7. doi: 10.7314/apjcp.2012.13.5.2241. Asian Pac J Cancer Prev. 2012. PMID: 22901201
-
The incidence of occult ovarian neoplasia and cancer in BRCA1/2 mutation carriers after the bilateral prophylactic salpingo-oophorectomy (PBSO): A single-center prospective study.Eur J Obstet Gynecol Reprod Biol. 2020 Apr;247:26-31. doi: 10.1016/j.ejogrb.2020.01.040. Epub 2020 Jan 30. Eur J Obstet Gynecol Reprod Biol. 2020. PMID: 32059136
-
Hormone therapy after prophylactic risk-reducing bilateral salpingo-oophorectomy in women who have BRCA gene mutation.Climacteric. 2016 Oct;19(5):419-22. doi: 10.1080/13697137.2016.1209396. Epub 2016 Jul 16. Climacteric. 2016. PMID: 27426853 Review.
-
Cardiovascular risk of BRCA1/2 mutation carriers: A review.Maturitas. 2016 Sep;91:135-9. doi: 10.1016/j.maturitas.2016.06.012. Epub 2016 Jun 22. Maturitas. 2016. PMID: 27451331 Review.
Cited by
-
Evaluation of psychosocial aspects in participants of cancer genetic counseling.Hered Cancer Clin Pract. 2017 Sep 20;15:13. doi: 10.1186/s13053-017-0073-x. eCollection 2017. Hered Cancer Clin Pract. 2017. PMID: 28943989 Free PMC article.
-
Distinctive psychological and social experiences of women choosing prophylactic oophorectomy for cancer prevention.Health Care Women Int. 2018 May;39(5):595-616. doi: 10.1080/07399332.2018.1424855. Epub 2018 Feb 2. Health Care Women Int. 2018. PMID: 29319429 Free PMC article.
-
The consequences of risk reducing salpingo-oophorectomy: the case for a coordinated approach to long-term follow up post surgical menopause.Fam Cancer. 2012 Sep;11(3):403-10. doi: 10.1007/s10689-012-9527-5. Fam Cancer. 2012. PMID: 22477030
-
Addressing sexual dysfunction after risk-reducing salpingo-oophorectomy: effects of a brief, psychosexual intervention.J Sex Med. 2015 Jan;12(1):189-97. doi: 10.1111/jsm.12713. Epub 2014 Oct 14. J Sex Med. 2015. PMID: 25311333 Free PMC article.
-
Psychological impact of risk-reducing surgery for gynecologic cancer among women with Lynch syndrome.Gynecol Oncol Rep. 2025 Mar 12;58:101719. doi: 10.1016/j.gore.2025.101719. eCollection 2025 Apr. Gynecol Oncol Rep. 2025. PMID: 40201898 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous